🇪🇺 Jakafi in European Union

Jakafi (RUXOLITINIB) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/005843
  • Local brand name: Opzelura
  • Status: approved

Jakafi in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Bone approved in European Union

Frequently asked questions

Is Jakafi approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Jakafi in European Union?

Incyte Corp is the originator. The local marketing authorisation holder may differ — check the official source linked above.